Human transferrin receptor can mediate SARS-CoV-2 infection
Proceedings of the National Academy of Sciences · 05.03.2024 · 121 (10)
DOI: 10.1073/pnas.2317026121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 26.02.2024. Verfasst von Zhiyi Liao und 21 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Laboratory of Peptides of Chinese Academy of Sciences, Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zool…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China (MOST), MOST | NSFC | National Science Fund for Distinguished Young Scholars (National Science Foundation for Distinguished Young Scholars), CAS | Kunming Institute of Zoology, Chinese Academy of Sciences (KIZ, CAS).
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been detected in almost all organs of coronavirus disease-19 patients, although some organs do not express angiotensin-converting enzyme-2 (ACE2), a known receptor of SARS-CoV-2, implying the presence of alternative receptors and/or co-receptors. Here, we show that the ubiquitously distributed human transferrin receptor (TfR), which binds to diferric transferrin to traffic between membrane and endosome for the iron delivery cycle, can ACE2-independently mediate SARS-CoV-2 infection. Human, not mouse TfR, interacts with Spike protein with a high affinity (K D ~2.95 nM) to mediate SARS-CoV-2 endocytosis. TfR knock-down (TfR-deficiency is lethal) and overexpression inhibit and promote SARS-CoV-2 infection, respectively. Humanized TfR expression enables SARS-CoV-2 infection in baby hamster kidney cells and C57 mice, which are known to be insusceptible to the virus infection. Soluble TfR, Tf, designed peptides blocking TfR-Spike interaction and anti-TfR antibody show significant anti-COVID-19 effects in cell and monkey models. Collectively, this report indicates that TfR is a receptor/co-receptor of SARS-CoV-2 mediating SARS-CoV-2 entry and infectivity by likely using the TfR trafficking pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Laboratory of Peptides of Chinese Academy of Sciences, Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology-Chinese University of Hong Kong Joint Laboratory of Bioresources a…
- Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
- School of Basic Medicine, Qingdao University, Qingdao 266071, China.
- Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming 650118, China.
- Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospi…
- Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650204, China.
ORCID-Profile: Zhiyi Liao, Zilei Duan, Ruomei Cheng, Gan Wang, Hongqi Liu, Dawit Adisu Tadese, Xiaozhong Peng, Ren Lai
Förderung
- Ministry of Science and Technology of the People's Republic of China (MOST)
- MOST | NSFC | National Science Fund for Distinguished Young Scholars (National Science Foundation for Distinguished Young Scholars)
- CAS | Kunming Institute of Zoology, Chinese Academy of Sciences (KIZ, CAS)
- | Applied Basic Research Foundation of Yunnan Province (Yunnan Province Applied and Basic Research Foundation)
- Kunming Science and Technology Bureau ()
- MOST | NSFC | Excellent Young Scientists Fund (Young Scientists Fund)
- 云南省科学技术厅| Applied Basic Research Foundation of Yunnan Province
Zitieren
APA
Liao, Z., Wang, C., Tang, X., Yang, M., Duan, Z., Liu, L., Lu, S., Ma, L., Cheng, R., Wang, G., Liu, H., Yang, S., Xu, J., Tadese, D. A., Mwangi, J., Kamau, P. M., Zhang, Z., Yang, L., Liao, G., …, & Lai, R. (2024). Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences, 121(10). https://doi.org/10.1073/pnas.2317026121
Vancouver
Liao Z, Wang C, Tang X, Yang M, Duan Z, Liu L, et al. Human transferrin receptor can mediate SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 2024;121(10). doi:10.1073/pnas.2317026121
BibTeX
@article{Liao2024,
author = {Liao, Zhiyi and Wang, Chaoming and Tang, Xiaopeng and Yang, Mengli and Duan, Zilei and Liu, Lei and Lu, Shuaiyao and Ma, Lei and Cheng, Ruomei and Wang, Gan and Liu, Hongqi and Yang, Shuo and Xu, Jingwen and Tadese, Dawit Adisu and Mwangi, James and Kamau, Peter Muiruri and Zhang, Zhiye and Yang, Lian and Liao, Guoyang and Zhao, Xudong and Peng, Xiaozhong and Lai, Ren},
title = {Human transferrin receptor can mediate SARS-CoV-2 infection},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {10},
doi = {10.1073/pnas.2317026121}
}
EUVIMED